Research map: Efficacy and Safety of Trimodal Dexmethylphenidate (CTx-1301) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: Results From a Phase 3, Randomized, Double-Blind, Fixed-Dose, Placebo-Controlled Trial

Back to the article

Papers in this map

  1. Statistical Power Analysis for the Behavioral Sciences · Jacob Cohen · 2013 · 25436 citations · Cited by this paper
  2. Access to Care in Pediatric Acute-Onset Neuropsychiatric Syndrome: A Survey of Families’ Journeys to and Experiences with Intravenous Immunoglobulin Treatment · 2026 · Related
  3. Using Effect Size—or Why the P Value Is Not Enough · Gail M. Sullivan · 2012 · 5656 citations · Cited by this paper
  4. Sex-Specific Effects of Relative Fat Mass on Attention-Deficit/Hyperactivity Disorder: Insights from the 1999–2004 National Health and Nutrition Examination Survey · 2026 · Related
  5. Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents · Mark L. Wolraich · 2019 · 1399 citations · Cited by this paper
  6. Clozapine for Severe Treatment-Resistant Disruptive Behaviors in Youth with Autism Spectrum Disorder: A Prospective Real-World Interventional Study · 2026 · Related
  7. The global prevalence of ADHD in children and adolescents: a systematic review and meta-analysis · Nader Salari · 2023 · 659 citations · Cited by this paper
  8. Pilot Trial of Adjunctive Curcumin for Treatment-Resistant Bipolar Depression in Youth: Focus on Inflammation and Oxidative Stress · 2026 · Related
  9. A Comparison of the Efficacy of Medications for Adult Attention-Deficit/Hyperactivity Disorder Using Meta-Analysis of Effect Sizes · Stephen V. Faraone · 2009 · 387 citations · Cited by this paper
  10. Letter: Eye Movement Desensitization Reprocessing and Transcranial Magnetic Stimulation in an Adolescent with Comorbid Major Depression Disorder and Posttraumatic Stress Disorder: A Case Report · 2026 · Related
  11. ADHD Prevalence Among U.S. Children and Adolescents in 2022: Diagnosis, Severity, Co-Occurring Disorders, and Treatment · Melissa L. Danielson · 2024 · 323 citations · Cited by this paper
  12. A Retrospective Study of Long-Term Associations of Behavioral Intervention Combined with Medications in Young Children with Attention-Deficit/Hyperactivity Disorder · 2026 · Related
  13. Evidence-based pharmacological treatment options for ADHD in children and adolescents · Konstantin Mechler · 2021 · 296 citations · Cited by this paper
  14. Low Emotional Awareness and Altered Frontostriatal Functional Connectivity During Reward Processing Prospectively Predict Depressive Symptoms in At-Risk Youth · 2026 · Related
  15. Adherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder – a systematic literature review · Vanja Sikirica · 2014 · 206 citations · Cited by this paper
  16. Risperidone Treatment in Children and Adolescents: A Naturalistic Observational Study of Metabolic, Cardiac, and Clinical Outcomes · 2026 · Related
  17. Experience of stress in parents of children with ADHD: A qualitative study · Sophie Leitch · 2019 · 154 citations · Cited by this paper
  18. Emotional Abuse as an Upstream Factor Influencing Non-Suicidal Self-Injury in Depressed Adolescents: A Network Analysis · 2025 · Related
  19. Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis · Raveen Hanwella · 2011 · 138 citations · Cited by this paper
  20. Methylphenidate and Psychotic Symptoms in Children and Adolescents: A Disproportionality Analysis on the WHO Safety Database (VigiBase) · 2026 · Related
  21. The impacts associated with having ADHD: an umbrella review · Blandine French · 2024 · 135 citations · Cited by this paper
  22. Systematic review of quality of life and functional outcomes in randomized placebo-controlled studies of medications for attention-deficit/hyperactivity disorder · David Coghill · 2017 · 123 citations · Cited by this paper
  23. Economic burden of attention-deficit/hyperactivity disorder among children and adolescents in the United States: a societal perspective · Jeff R. Schein · 2022 · 78 citations · Cited by this paper
  24. An update on the pharmacokinetic considerations in the treatment of ADHD with long-acting methylphenidate and amphetamine formulations · Ann Catherine Childress · 2019 · 74 citations · Cited by this paper
  25. Unmet Needs Associated with Attention-Deficit/Hyperactivity Disorder in Eight European Countries as Reported by Caregivers and Adolescents: Results from Qualitative Research · Vanja Sikirica · 2014 · 65 citations · Cited by this paper
  26. Efficacy and Safety of Extended-Release Dexmethylphenidate Compared with d,l -Methylphenidate and Placebo in the Treatment of Children with Attention-Deficit/Hyperactivity Disorder: A 12-Hour Laboratory Classroom Study · Rafael Muniz · 2008 · 44 citations · Cited by this paper
  27. A Randomized, Double-Blind, Crossover Study of Once-Daily Dexmethylphenidate in Children with Attention-Deficit Hyperactivity Disorder · Matthew N. Brams · 2008 · 42 citations · Cited by this paper
  28. Early Morning Functioning in Stimulant-Treated Children and Adolescents with Attention-Deficit/Hyperactivity Disorder, and its Impact on Caregivers · Floyd R. Sallee · 2015 · 39 citations · Cited by this paper
  29. Efficacy and Safety of Dexmethylphenidate Extended-Release Capsules Administered Once Daily to Children with Attention-Deficit/Hyperactivity Disorder · Ann Catherine Childress · 2009 · 34 citations · Cited by this paper
  30. Understanding the Effect Size of Lisdexamfetamine Dimesylate for Treating ADHD in Children and Adults · Stephen V. Faraone · 2010 · 33 citations · Cited by this paper
  31. A Randomized, Double-Blind, Placebo-Controlled Study of HLD200, a Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder: An Evaluation of Safety and Efficacy Throughout the Day and Across Settings · Ann Catherine Childress · 2019 · 28 citations · Cited by this paper
  32. Early Morning Functional Impairments in Stimulant-Treated Children with Attention-Deficit/Hyperactivity Disorder Versus Controls: Impact on the Family · Stephen V. Faraone · 2017 · 26 citations · Cited by this paper
  33. Novel Formulations of ADHD Medications: Stimulant Selection and Management · Ann Catherine Childress · 2021 · 13 citations · Cited by this paper
  34. Efficacy and Safety of a Long-Acting Multilayer-Release Methylphenidate Formulation (PRC-063) in the Treatment of Adolescent Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Clinical Trial with a 6-Month Open-Label Extension · Margaret Danielle Weiss · 2021 · 13 citations · Cited by this paper
  35. Safety and Tolerability of Serdexmethylphenidate/Dexmethylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder: A 12-Month, Open-Label Safety Study · Ann Catherine Childress · 2023 · 7 citations · Cited by this paper
  36. Are all ADHD medications created equal? Exploring the differences that enable evening dosing · Gregory W. Mattingly · 2024 · 3 citations · Cited by this paper

Source: OpenAlex (CC0)